Business Paid
Bioceltix wins EU funding
04:38
Bioceltix has secured a positive assessment from the Polish Agency for Enterprise Development (PARP) for its pharmaceutical plant project, submitted under the “SMART Path” competition within the European Funds for Modern Economy programme.
The Wrocław-based biotech company plans to build and launch a facility for producing advanced therapy veterinary medicines.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
